EQT and KKR compete for Qiagen acquisition

Statements (8)

1. ● Neutral

   EQT and KKR are competing for interest in the diagnostic company Qiagen.

   wiwo.deOct 21, 2026 09:45 UTCHigh importance
2. ● Neutral

   EQT is in advanced negotiations to acquire Qiagen for over $10 billion

   privateequitywire.co.ukOct 21, 2026 08:58 UTCHigh importance
3. ● Neutral

   EQT and KKR are competing for the diagnostic company Qiagen.

   wiwo.deOct 21, 2026 08:24 UTCHigh importance
4. ▲ Bullish

   A competitor is also submitting an acquisition offer for Qiagen.

   manager-magazin.deOct 21, 2026 08:06 UTC
5. ▲ Bullish

   EQT is offering an acquisition offer for Qiagen.

   manager-magazin.deOct 21, 2026 08:06 UTCHigh importance
6. ▲ Bullish

   Qiagen's shares benefited from new takeover speculation.

   deraktionaer.deOct 21, 2026 05:38 UTC
7. ● Neutral

   EQT is in advanced talks to buy Qiagen for a testing firm

   reuters.comOct 20, 2026 18:55 UTC
8. ● Neutral

   EQT is in negotiations to acquire Qiagen, a German medical technology company.

   di.seOct 20, 2026 17:11 UTCHigh importance